IRIS
GENNARI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.331
EU - Europa 9.295
AS - Asia 5.771
SA - Sud America 1.299
AF - Africa 102
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 13
Totale 29.833
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.191
CN - Cina 2.192
RU - Federazione Russa 2.088
SG - Singapore 1.913
GB - Regno Unito 1.638
IE - Irlanda 1.525
BR - Brasile 1.127
IT - Italia 919
UA - Ucraina 888
SE - Svezia 668
DE - Germania 502
FR - Francia 486
HK - Hong Kong 476
KR - Corea 379
VN - Vietnam 311
FI - Finlandia 296
IN - India 109
TR - Turchia 86
CA - Canada 73
AR - Argentina 70
BD - Bangladesh 62
ES - Italia 40
NL - Olanda 40
MX - Messico 38
IQ - Iraq 37
PL - Polonia 35
ZA - Sudafrica 34
CZ - Repubblica Ceca 29
ID - Indonesia 29
BE - Belgio 28
EC - Ecuador 27
AT - Austria 24
PK - Pakistan 22
JP - Giappone 20
CO - Colombia 19
CI - Costa d'Avorio 18
CL - Cile 18
LT - Lituania 17
SA - Arabia Saudita 15
UZ - Uzbekistan 15
IR - Iran 13
AU - Australia 12
VE - Venezuela 12
EU - Europa 11
NP - Nepal 11
GR - Grecia 10
MA - Marocco 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
DK - Danimarca 9
DZ - Algeria 9
HU - Ungheria 9
UY - Uruguay 9
IL - Israele 8
KE - Kenya 8
SY - Repubblica araba siriana 8
EG - Egitto 7
JM - Giamaica 7
NZ - Nuova Zelanda 7
AZ - Azerbaigian 6
JO - Giordania 6
LV - Lettonia 6
PY - Paraguay 6
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
KZ - Kazakistan 5
TN - Tunisia 5
AM - Armenia 4
CH - Svizzera 4
ET - Etiopia 4
GE - Georgia 4
HN - Honduras 4
IM - Isola di Man 4
PT - Portogallo 4
AL - Albania 3
BH - Bahrain 3
HR - Croazia 3
LB - Libano 3
LU - Lussemburgo 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
BG - Bulgaria 2
BY - Bielorussia 2
CR - Costa Rica 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MN - Mongolia 2
MW - Malawi 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CG - Congo 1
Totale 29.812
Salva come PNG Salva come JPEG
Città #
Dallas 2.609
Dublin 1.508
Fairfield 1.499
Southend 1.400
Singapore 980
Ashburn 903
Chandler 712
Jacksonville 709
Woodbridge 664
Santa Clara 619
Wilmington 568
Houston 556
Moscow 546
Seattle 536
Cambridge 530
Beijing 496
Hong Kong 473
Hefei 393
Seoul 377
Princeton 318
Ann Arbor 307
Siena 227
Nanjing 222
Los Angeles 139
Helsinki 110
The Dalles 110
Ho Chi Minh City 103
Boardman 101
Buffalo 99
San Diego 97
Shanghai 90
Nanchang 84
Milan 81
São Paulo 81
Dong Ket 72
Council Bluffs 67
London 67
Izmir 65
Munich 65
San Mateo 62
Shenyang 59
Florence 58
New York 58
Redondo Beach 52
Tianjin 51
Columbus 49
Dearborn 47
Rome 46
Bengaluru 45
Hanoi 43
Hebei 41
Belo Horizonte 40
Rio de Janeiro 39
Jiaxing 37
Kunming 36
Changsha 34
San Francisco 32
Brooklyn 28
Warsaw 27
Brussels 26
Düsseldorf 26
Turku 26
Chicago 25
Toronto 25
Redwood City 24
Brasília 22
Lappeenranta 22
Málaga 22
Norwalk 22
Nuremberg 22
Zhengzhou 21
Denver 20
Hangzhou 20
Jinan 20
Tokyo 19
Abidjan 18
Atlanta 18
Falls Church 18
Porto Alegre 18
Stockholm 18
Boston 17
Guangzhou 17
Johannesburg 17
Curitiba 16
Dhaka 16
Fremont 16
Vienna 16
Frankfurt am Main 15
Menlo Park 15
Montreal 15
Poplar 15
Venezia 15
Portsmouth 14
Brno 13
Campinas 13
Guarulhos 13
Ningbo 13
Olomouc 13
Phoenix 13
Tashkent 13
Totale 20.214
Salva come PNG Salva come JPEG
Nome #
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes mellitus: friends or foes to bone health? a narrative review of clinical studies 1.191
null 398
Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation 300
Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study 278
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 276
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone 247
Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women 244
Aromatase activity and bone loss in men 238
A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease 229
Bazedoxifene for the prevention of postmenopausal osteoporosis 228
Falls, fractures and vitamin D: a never-ending story? 227
Characteristics and familial aggregation of Paget's disease of bone in Italy 225
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. 223
Aromatase activity and bone homeostasis in men 219
The association of body composition and sexhormones with quantitative ultrasound parameters at the calcaneus and phalanxes in elderly women. 214
Age-related decline of bone mass and intestinal calcium absorption in normal males 211
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease 210
Dual X-ray absorptiometry and bone ultrasonography in patients with Rett Syndrome 207
Absence of correlation between BMP-4 polymorphism and postmenopausal osteoporosis in Italian women 206
Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls 204
Endocrine actions of osteocalcin 202
ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor 201
Effect of Electromagnetic Fields on Bone Mineral Density and Biochemical Markers of Bone Turnover in Osteoporosis: A single-Blind, Randomized Pilot Study 199
The usefulness of quantitative ultrasound (QUS) measurements in the evaluation of skeletal status in newborns and in children 199
Corretto uso dei marcatori del rimodellamento osseo 199
Aromatase activity and bone loss 196
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone 193
Bone metabolism in men: role of aromatase activity 191
Undiagnosed vertebral fractures influence quality of life in postmenopausal women with reduced ultrasound parameters. 190
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women 189
Longitudinal association between sex hormone levels, bone loss and bone turnover in elderly men. 188
Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women 187
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapy on bone metabolism 182
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis 180
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. 180
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family 179
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget’s disease of bone 177
Misdiagnosis of vertebral fractures on local radiographic readings of the multicentre POINT (Prevalence of Osteoporosis in INTernal medicine) study 177
The effects of zoledronic acid on serum lipids in multiple myeloma patients 174
The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study 174
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone 174
Effect of electromagnetic fields on bone mineral density and biochemical markers of bone turnover in osteoporosis: a single-blind, randomized, pilot study 173
The combined use of ultrasound and densitometry in the prediction of vertebral fracture 171
Appropriate models for novel osteoporosis drug discovery and future perspectives 170
Bona fide genetic associations with bone mineral density 169
Left ventricular hypertrophy differences in male professional runners and in young patients suffering from mild hypertension 169
CALCITRIOLO E OSTEOPOROSI 169
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene 168
Adiponectin may play a crucial role in the metabolic effects of GLP-1RAs treatment in patients with Type 2 Diabetes Mellitus: a preliminary longitudinal study 166
Evidence for increased clinical severity of familial and sporadic Paget’s disease of bone in Campania, southern Italy 166
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 166
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease 166
Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy 165
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone 165
Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function 165
aromatase deficiency and male osteoporosis 164
Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells 163
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis 163
Update on the pharmacogenetics of the vitamin D receptor and osteoporosis 162
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 162
Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men 161
Bisphosphonates target B cells to enhance humoral immune responses 161
Effect of electromagnetic fields on bone mineral density and biochemical markers of bone turnover in osteoporosis: a single-blind, randomized pilot study 160
Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis 160
Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. 159
The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women 159
Prevalence of Paget’s disease of bone in Italy 159
Osteoporosis in men: pathophysiology and treatment 159
Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density 157
Does calcium supplementation reduce the risk of osteoporotic fracture and bone loss? 156
Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk 156
Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree 156
Paget's disease of bone: epidemiology, pathogenesis and pharmacotherapy 156
FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women 154
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 154
Perspectives in the treatment and prevention of osteoporosis 152
Mechanisms of impaired bone strength in type 1 and 2 diabetes 151
PTH in the pathogenesis and treatment of glucocorticoid-induced osteoporosis 151
Idiopathic osteoporosis in men 151
Analysis of Usual Consumption of Vitamin D Among Adult Individuals in Italy 150
Quantitative ultrasound and bone mineral density in patients with primary hyperparathyroidism before and after surgical treatment 150
Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women 150
Ospemifene use in postmenopausal women 149
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 149
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma 149
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis 148
Paget’s disease of bone in Italy. 148
Usefulness of bone quantitative ultrasound in management of osteoporosis in men 148
Genome-wide association identifies three new susceptibilityloci for Paget's disease of bone 148
Apporto nutrizionale di vitamina D in Italia [Feeding and vitamin D in Italy] 147
Bone fragility in men: where are we? 145
Osteoporosis in men: pathophysiology and treatment 145
MicroRNAs in bone diseases 143
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women 142
Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms 142
Estrogen and fracture risk in men 141
Identification of Single Nucleotide Polymorphisms (SNPs) contributing to bone mineral density and fractures: a DNA microarray based study 140
Update on the pathogenesis and genetics of Paget's disease of bone 139
The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma 139
Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis 139
Totale 18.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.767 0 0 0 0 0 311 99 484 267 173 222 211
2021/20221.957 125 280 85 203 69 57 87 69 126 228 178 450
2022/20232.698 185 176 358 391 293 588 55 201 271 47 95 38
2023/20242.299 230 77 218 73 54 536 745 45 18 59 46 198
2024/20255.041 105 268 371 239 612 285 173 294 446 278 494 1.476
2025/20268.348 995 1.816 2.256 1.303 1.873 105 0 0 0 0 0 0
Totale 30.193